Accuracy of Buffy Coat in the Diagnosis of Disseminated Histoplasmosis in AIDS-Patients in an Endemic Area of Brazil
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Population and Research Design
2.2. Buffy Coat Assay
2.3. Statistical Analysis
2.4. Ethical Aspects
3. Results
3.1. Study Design
3.2. Population Baseline
3.3. Sequential Tests
3.4. Accuracy Tests
4. Discussion
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Wheat, L.; Azar, M.; Bahr, N.; Spec, A.; Relich, R.; Hage, C. Histoplasmosis. Infect. Dis. Clin. N. Am. 2016, 30, 207–227. [Google Scholar] [CrossRef] [PubMed]
- Benedict, K.; Mody, R.K. Epidemiology of histoplasmosis outbreaks, United States, 1938–2013. Emerg. Infect. Dis. 2016, 22, 370. [Google Scholar] [CrossRef] [PubMed]
- Guimarães, A.J.; Cerqueira, M.D.; Nosanchuk, J.D. Surface Architecture of Histoplasma Capsulatum. Front. Microbiol. 2011, 2, 225. [Google Scholar] [CrossRef] [PubMed]
- Correia, F.G.S.; Alencar, C.H.; Damasceno, L.S.; Ramos, I.C.; Pontes, L.B.; Leitão, T.M.J.S. Spatial distribution of disseminated histoplasmosis and AIDS co-infection in an endemic area of Northeastern Brazil. Rer. Soc. Bras. Med. Trop. 2016, 49, 227–231. [Google Scholar] [CrossRef] [PubMed]
- Damasceno, L.S.; Ramos, A.N., Jr.; Alencar, C.H.; Gonçalves, M.V.F.; de Mesquita, J.R.L.; Soares, A.T.D.; Coutinho, A.G.; Dantas, C.C.; Leitão Tdom, M. Disseminated histoplasmosis in HIV-infected patients: Determinants of relapse and mortality in a north-eastern area of Brazil. Mycoses 2014, 57, 406–413. [Google Scholar] [CrossRef] [PubMed]
- Nacher, M.; Adenis, A.; Arathoon, E.; Samayoa, B.; Lau-Bonilla, D.; Gomez, B.L.; Tobon, A.; Caceres, D.; Silva, S.M.; da Costa, M.M.; et al. Disseminated histoplasmosis in Central and South America, the invisible elephant: The lethal blind spot of international health organizations. AIDS 2016, 30, 167–170. [Google Scholar]
- Nacher, M.; Adenis, A.; Mc Donald, S.; Gomes, M.D.S.M.; Singh, S.; Lima, I.L.; Leite, R.M.; Hermelijn, S.; Wongsokarijo, M.; Eer, M.V.; et al. Disseminated histoplasmosis in HIV-infected patients in South America: A neglected killer continues on its rampage. PLoS Negl. Trop. Dis. 2013, 7, e2319. [Google Scholar] [CrossRef]
- Azar, M.M.; Hage, C.A. Laboratory diagnostics for histoplasmosis. J. Clin. Microbiol. 2017, 55, 1612–1620. [Google Scholar] [CrossRef]
- Wheat, L.J.; Garringer, T.; Brizendine, E.; Connolly, P. Diagnosis of histoplasmosis by antigen detection based upon experience at the histoplasmosis reference laboratory. Diagn. Microbiol. Infect. Dis. 2002, 43, 29–37. [Google Scholar] [CrossRef]
- Couppie, P.; Aznar, C.; Carme, B.; Nacher, M. American histoplasmosis in developing countries with a special focus on patients with HIV: Diagnosis, treatment, and prognosis. Curr. Opin. Infect. Dis. 2006, 19, 443–449. [Google Scholar] [CrossRef]
- Ramos, I.C.; Soares, Y.C.; Damasceno, L.S.; Libório, M.P.; Farias, L.A.B.G.; Heukelbach, J.; Alencar, C.H.M.; Leitão, T.M.J.S. Predictive factors for disseminated histoplasmosis in AIDS patients with fever admitted to a reference hospital in Brazil. Rer. Soc. Bras. Med. Trop. 2018, 51, 479–484. [Google Scholar] [CrossRef] [PubMed]
- Brilhante, R.S.; Fechine, M.A.; Mesquita, J.R.; Cordeiro, R.A.; Rocha, M.F.; Monteiro, A.J.; Lima, R.A.; Caetano, É.P.; Pereira, J.F.; Castelo-Branco, D.S.; et al. Histoplasmosis in HIV-positive patients in Ceará, Brazil: Clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates. Trans. R. Soc. Trop. Med. Hyg. 2012, 106, 484–488. [Google Scholar] [CrossRef] [PubMed]
- Hage, C.A.; Azar, M.M.; Bahr, N.; Loyd, J.; Wheat, L.J. Histoplasmosis: Up-to-date evidence-based approach to diagnosis and management. Semin. Respir. Crit. Care Med. 2015, 36, 729–745. [Google Scholar] [PubMed]
- Nacher, M.; Blanchet, D.; Bongomin, F.; Chakrabarti, A.; Couppié, P.; Demar, M.; Denning, D.W.; Djossou, F.; Epelboin, L.; Govender, N.; et al. Histoplasma capsulatum antigen detection tests as an essential diagnostic tool for patients with advanced HIV disease in low and middle income countries: A systematic review of diagnostic accuracy studies. PLoS Negl. Trop. Dis. 2018, 12, e0006802. [Google Scholar] [CrossRef] [PubMed]
- Kauffman, C.A. Histoplasmosis: A clinical and laboratory update. Clin. Microbiol. Rev. 2007, 20, 115–132. [Google Scholar] [CrossRef] [PubMed]
- De Pauw, B.W.T.; Donnelly, J.P.; Stevens, D.A.; Edwards, J.E.; Calandra, T.; Pappas, P.G.; Maertens, J.; Lortholary, O.; Kauffman, C.A.; Denning, D.W.; et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 2008, 46, 1813–1821. [Google Scholar] [PubMed]
- Sevestre, J.; Hasseine, L. Disseminated Histoplasmosis. N. Engl. J. Med. 2019, 380, e13. [Google Scholar] [CrossRef] [PubMed]
- Nacher, M.; Adenis, A.; Sambourg, E.; Huber, F.; Abboud, P.; Epelboin, L.; Epelboin, L.; Mosnier, E.; Vantilcke, V.; Dufour, J.; et al. Histoplasmosis or tuberculosis in HIV-infected patients in the amazon: What should be treated first? PLoS Negl. Trop. Dis. 2014, 8, e3290. [Google Scholar] [CrossRef] [PubMed]
- Pontes, L.B.; Leitão, T.M.J.S.; Lima, G.G.; Gerhard, E.S.; Fernandes, T.A. Clinical and evolutionary characteristics of 134 patients with disseminated histoplasmosis associated with AIDS in the State of Ceara. Rev. Soc. Bras. Med. Trop. 2010, 43, 27–31. [Google Scholar] [CrossRef] [PubMed]
- De Franchesco Daher, E.; de Sousa Barros, F.A.; da Silva Júnior, G.B.; Takeda, C.F.; Mota, R.M.; Ferreira, M.T.; Martins, J.C.; Oliveira, S.A.; Gutiérrez-Adrianzén, O.A. Risk factors for death in acquired immunodeficiency syndrome–associated disseminated histoplasmosis. Am. J. Trop. Med Hyg. 2006, 74, 600–603. [Google Scholar] [CrossRef]
- Cano-Torres, J.O.; Olmedo-Reneaum, A.; Esquivel-Sánchez, J.M.; Camiro-Zuñiga, A.; Pérez-Carrisoza, A.; Madrigal-Iberri, C.; Flores-Miranda, R.; Ramírez-González, L.E.; Belaunzarán-Zamudio, P.F. Progressive disseminated histoplasmosis in Latin America and the Caribbean in people receiving highly active antiretroviral therapy for HIV infection: A systematic review. Med. Mycol. 2019, 143. [Google Scholar] [CrossRef] [PubMed]
- Adenis, A.; Nacher, M.; Hanf, M.; Vantilcke, V.; Boukhari, R.; Blachet, D.; Demar, M.; Aznar, C.; Carme, B.; Couppie, P. HIV-associated histoplasmosis early mortality and incidence trends: From neglect to priority. PLoS Negl. Trop. Dis. 2014, 8, e3100. [Google Scholar] [CrossRef] [PubMed]
- Caceres, D.; Minderman, M.; Cheney, L.; Gomez, B.; Wheat, L.; Chiller, T.; Lindsley, M. Evaluation of a Histoplasma antigen Lateral Flow Assay for the rapid diagnosis of progressive disseminated histoplasmosis in AIDS patients. Med. Mycol. 2018, 56, S158. [Google Scholar]
- Hage, C.A.; Ribes, J.A.; Wengenack, N.L.; Baddour, L.M.; Assi, M.; McKinsey, D.S.; Hammoud, K.; Alapat, D.; Babady, N.E.; Parker, M.; et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin. Infect. Dis. 2011, 53, 448–454. [Google Scholar] [CrossRef] [PubMed]
Histoplasma Detected by Culture | |||
---|---|---|---|
Variables | Positive | Negative | p |
Age mean (SD) | 33.9(10.7) | 37.4(11.5) | 0.109 |
Sex | |||
Male (%) | 49 (80.3%) | 227 (75.7%) | 0.510 |
Female (%) | 12 (19.7%) | 73 (24.3%) | |
CD4 cells/µL, mean (SD) | 139.3 (213.3) | 191.7 (230.1) | 0.014 |
Death | 11 (18.0%) | 62 (20.7%) | 0.729 |
Accuracy Test | ||||||
---|---|---|---|---|---|---|
Buffy coat smear | Sensitivity | Specificity | PPV 1 | NPV 2 | FP 3 | FN 4 |
One test | 25.9% | 100.0% | 100.0% | 88.5% | 0.0% | 11.5% |
First and Second test | 32.2% | 100.0% | 100.0% | 88.3% | 0.0% | 11.7% |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Leitão, T.M.J.S.; Oliveira Filho, A.M.P.; Sousa Filho, J.E.P.; Tavares, B.M.; Mesquita, J.R.L.; Farias, L.A.B.G.; Mota, R.S.; Nacher, M.; Damasceno, L.S. Accuracy of Buffy Coat in the Diagnosis of Disseminated Histoplasmosis in AIDS-Patients in an Endemic Area of Brazil. J. Fungi 2019, 5, 47. https://doi.org/10.3390/jof5020047
Leitão TMJS, Oliveira Filho AMP, Sousa Filho JEP, Tavares BM, Mesquita JRL, Farias LABG, Mota RS, Nacher M, Damasceno LS. Accuracy of Buffy Coat in the Diagnosis of Disseminated Histoplasmosis in AIDS-Patients in an Endemic Area of Brazil. Journal of Fungi. 2019; 5(2):47. https://doi.org/10.3390/jof5020047
Chicago/Turabian StyleLeitão, Terezinha M. J. Silva, Antonio M. P. Oliveira Filho, José Evaldo P. Sousa Filho, Bruno M. Tavares, Jacó R. L. Mesquita, Luís Arthur B. G. Farias, Rosa S. Mota, Mathieu Nacher, and Lisandra S. Damasceno. 2019. "Accuracy of Buffy Coat in the Diagnosis of Disseminated Histoplasmosis in AIDS-Patients in an Endemic Area of Brazil" Journal of Fungi 5, no. 2: 47. https://doi.org/10.3390/jof5020047
APA StyleLeitão, T. M. J. S., Oliveira Filho, A. M. P., Sousa Filho, J. E. P., Tavares, B. M., Mesquita, J. R. L., Farias, L. A. B. G., Mota, R. S., Nacher, M., & Damasceno, L. S. (2019). Accuracy of Buffy Coat in the Diagnosis of Disseminated Histoplasmosis in AIDS-Patients in an Endemic Area of Brazil. Journal of Fungi, 5(2), 47. https://doi.org/10.3390/jof5020047